 | • レポートコード：MRC2-11QY00874 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は凝固防止剤のグローバル市場について調査・分析したレポートです。種類別（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接第Xa因子阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他）市場規模、用途別（VTE、ACS / MI、AF、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別凝固防止剤の競争状況、市場シェア ・世界の凝固防止剤市場：種類別市場規模 2015年-2020年（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接第Xa因子阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他） ・世界の凝固防止剤市場：種類別市場規模予測 2021年-2026年（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接第Xa因子阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他） ・世界の凝固防止剤市場：用途別市場規模 2015年-2020年（VTE、ACS / MI、AF、その他） ・世界の凝固防止剤市場：用途別市場規模予測 2021年-2026年（VTE、ACS / MI、AF、その他） ・北米の凝固防止剤市場分析：米国、カナダ ・ヨーロッパの凝固防止剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの凝固防止剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の凝固防止剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの凝固防止剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Bayer、Boehringer Ingelheim、Johnson & Johnson、Genentech (Roche)、AstraZeneca、Bristol-Myers Squibb、Aspen、Lilly、Otsuka、Pfizer、Daiichi Sankyo、The Medicines Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Decoagulant Market
The global Decoagulant market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Decoagulant Scope and Market Size
Decoagulant market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Decoagulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Decoagulant market is segmented into
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Segment by Application, the Decoagulant market is segmented into
VTE
ACS/MI
AF
Others
Regional and Country-level Analysis
The Decoagulant market is analysed and market size information is provided by regions (countries).
The key regions covered in the Decoagulant market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Decoagulant Market Share Analysis
Decoagulant market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Decoagulant business, the date to enter into the Decoagulant market, Decoagulant product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
1 Study Coverage
1.1 Decoagulant Product Introduction
1.2 Market Segments
1.3 Key Decoagulant Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Decoagulant Market Size Growth Rate by Type
1.4.2 Platelet aggregation inhibitors (PAI)
1.4.3 Low-molecular-weight Heparin (LMWH)
1.4.4 Direct thrombin inhibitor (DTI)
1.4.5 Direct factor Xa inhibitors (DFXa)
1.4.6 Vitamin K antagonists (VKA)
1.4.7 Others
1.5 Market by Application
1.5.1 Global Decoagulant Market Size Growth Rate by Application
1.5.2 VTE
1.5.3 ACS/MI
1.5.4 AF
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Decoagulant Market Size, Estimates and Forecasts
2.1.1 Global Decoagulant Revenue 2015-2026
2.1.2 Global Decoagulant Sales 2015-2026
2.2 Global Decoagulant, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Decoagulant Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Decoagulant Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Decoagulant Competitor Landscape by Players
3.1 Decoagulant Sales by Manufacturers
3.1.1 Decoagulant Sales by Manufacturers (2015-2020)
3.1.2 Decoagulant Sales Market Share by Manufacturers (2015-2020)
3.2 Decoagulant Revenue by Manufacturers
3.2.1 Decoagulant Revenue by Manufacturers (2015-2020)
3.2.2 Decoagulant Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Decoagulant Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Decoagulant Revenue in 2019
3.2.5 Global Decoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Decoagulant Price by Manufacturers
3.4 Decoagulant Manufacturing Base Distribution, Product Types
3.4.1 Decoagulant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Decoagulant Product Type
3.4.3 Date of International Manufacturers Enter into Decoagulant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Decoagulant Market Size by Type (2015-2020)
4.1.1 Global Decoagulant Sales by Type (2015-2020)
4.1.2 Global Decoagulant Revenue by Type (2015-2020)
4.1.3 Decoagulant Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Decoagulant Market Size Forecast by Type (2021-2026)
4.2.1 Global Decoagulant Sales Forecast by Type (2021-2026)
4.2.2 Global Decoagulant Revenue Forecast by Type (2021-2026)
4.2.3 Decoagulant Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Decoagulant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Decoagulant Market Size by Application (2015-2020)
5.1.1 Global Decoagulant Sales by Application (2015-2020)
5.1.2 Global Decoagulant Revenue by Application (2015-2020)
5.1.3 Decoagulant Price by Application (2015-2020)
5.2 Decoagulant Market Size Forecast by Application (2021-2026)
5.2.1 Global Decoagulant Sales Forecast by Application (2021-2026)
5.2.2 Global Decoagulant Revenue Forecast by Application (2021-2026)
5.2.3 Global Decoagulant Price Forecast by Application (2021-2026)
6 North America
6.1 North America Decoagulant by Country
6.1.1 North America Decoagulant Sales by Country
6.1.2 North America Decoagulant Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Decoagulant Market Facts & Figures by Type
6.3 North America Decoagulant Market Facts & Figures by Application
7 Europe
7.1 Europe Decoagulant by Country
7.1.1 Europe Decoagulant Sales by Country
7.1.2 Europe Decoagulant Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Decoagulant Market Facts & Figures by Type
7.3 Europe Decoagulant Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Decoagulant by Region
8.1.1 Asia Pacific Decoagulant Sales by Region
8.1.2 Asia Pacific Decoagulant Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Decoagulant Market Facts & Figures by Type
8.3 Asia Pacific Decoagulant Market Facts & Figures by Application
9 Latin America
9.1 Latin America Decoagulant by Country
9.1.1 Latin America Decoagulant Sales by Country
9.1.2 Latin America Decoagulant Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Decoagulant Market Facts & Figures by Type
9.3 Central & South America Decoagulant Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Decoagulant by Country
10.1.1 Middle East and Africa Decoagulant Sales by Country
10.1.2 Middle East and Africa Decoagulant Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Decoagulant Market Facts & Figures by Type
10.3 Middle East and Africa Decoagulant Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Decoagulant Products Offered
11.1.5 Sanofi Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description and Business Overview
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Decoagulant Products Offered
11.2.5 Bayer Related Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description and Business Overview
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Decoagulant Products Offered
11.3.5 Boehringer Ingelheim Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Decoagulant Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Corporation Information
11.5.2 Genentech (Roche) Description and Business Overview
11.5.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Genentech (Roche) Decoagulant Products Offered
11.5.5 Genentech (Roche) Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Decoagulant Products Offered
11.6.5 AstraZeneca Related Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description and Business Overview
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Decoagulant Products Offered
11.7.5 Bristol-Myers Squibb Related Developments
11.8 Aspen
11.8.1 Aspen Corporation Information
11.8.2 Aspen Description and Business Overview
11.8.3 Aspen Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Aspen Decoagulant Products Offered
11.8.5 Aspen Related Developments
11.9 Lilly
11.9.1 Lilly Corporation Information
11.9.2 Lilly Description and Business Overview
11.9.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Lilly Decoagulant Products Offered
11.9.5 Lilly Related Developments
11.10 Otsuka
11.10.1 Otsuka Corporation Information
11.10.2 Otsuka Description and Business Overview
11.10.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Otsuka Decoagulant Products Offered
11.10.5 Otsuka Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Decoagulant Products Offered
11.1.5 Sanofi Related Developments
11.12 Daiichi Sankyo
11.12.1 Daiichi Sankyo Corporation Information
11.12.2 Daiichi Sankyo Description and Business Overview
11.12.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Daiichi Sankyo Products Offered
11.12.5 Daiichi Sankyo Related Developments
11.13 The Medicines Company
11.13.1 The Medicines Company Corporation Information
11.13.2 The Medicines Company Description and Business Overview
11.13.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
11.13.4 The Medicines Company Products Offered
11.13.5 The Medicines Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Decoagulant Market Estimates and Projections by Region
12.1.1 Global Decoagulant Sales Forecast by Regions 2021-2026
12.1.2 Global Decoagulant Revenue Forecast by Regions 2021-2026
12.2 North America Decoagulant Market Size Forecast (2021-2026)
12.2.1 North America: Decoagulant Sales Forecast (2021-2026)
12.2.2 North America: Decoagulant Revenue Forecast (2021-2026)
12.2.3 North America: Decoagulant Market Size Forecast by Country (2021-2026)
12.3 Europe Decoagulant Market Size Forecast (2021-2026)
12.3.1 Europe: Decoagulant Sales Forecast (2021-2026)
12.3.2 Europe: Decoagulant Revenue Forecast (2021-2026)
12.3.3 Europe: Decoagulant Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Decoagulant Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Decoagulant Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Decoagulant Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Decoagulant Market Size Forecast by Region (2021-2026)
12.5 Latin America Decoagulant Market Size Forecast (2021-2026)
12.5.1 Latin America: Decoagulant Sales Forecast (2021-2026)
12.5.2 Latin America: Decoagulant Revenue Forecast (2021-2026)
12.5.3 Latin America: Decoagulant Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Decoagulant Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Decoagulant Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Decoagulant Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Decoagulant Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Decoagulant Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Decoagulant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Decoagulant Market Segments
Table 2. Ranking of Global Top Decoagulant Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Decoagulant Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Platelet aggregation inhibitors (PAI)
Table 5. Major Manufacturers of Low-molecular-weight Heparin (LMWH)
Table 6. Major Manufacturers of Direct thrombin inhibitor (DTI)
Table 7. Major Manufacturers of Direct factor Xa inhibitors (DFXa)
Table 8. Major Manufacturers of Vitamin K antagonists (VKA)
Table 9. Major Manufacturers of Others
Table 10. Global Decoagulant Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 11. Global Decoagulant Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 12. Global Decoagulant Sales by Regions 2015-2020 (K Doses)
Table 13. Global Decoagulant Sales Market Share by Regions (2015-2020)
Table 14. Global Decoagulant Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Decoagulant Sales by Manufacturers (2015-2020) (K Doses)
Table 16. Global Decoagulant Sales Share by Manufacturers (2015-2020)
Table 17. Global Decoagulant Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Decoagulant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decoagulant as of 2019)
Table 19. Decoagulant Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Decoagulant Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Decoagulant Price (2015-2020) (USD/Dose)
Table 22. Decoagulant Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Decoagulant Product Type
Table 24. Date of International Manufacturers Enter into Decoagulant Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Decoagulant Sales by Type (2015-2020) (K Doses)
Table 27. Global Decoagulant Sales Share by Type (2015-2020)
Table 28. Global Decoagulant Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Decoagulant Revenue Share by Type (2015-2020)
Table 30. Decoagulant Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 31. Global Decoagulant Sales by Application (2015-2020) (K Doses)
Table 32. Global Decoagulant Sales Share by Application (2015-2020)
Table 33. North America Decoagulant Sales by Country (2015-2020) (K Doses)
Table 34. North America Decoagulant Sales Market Share by Country (2015-2020)
Table 35. North America Decoagulant Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Decoagulant Revenue Market Share by Country (2015-2020)
Table 37. North America Decoagulant Sales by Type (2015-2020) (K Doses)
Table 38. North America Decoagulant Sales Market Share by Type (2015-2020)
Table 39. North America Decoagulant Sales by Application (2015-2020) (K Doses)
Table 40. North America Decoagulant Sales Market Share by Application (2015-2020)
Table 41. Europe Decoagulant Sales by Country (2015-2020) (K Doses)
Table 42. Europe Decoagulant Sales Market Share by Country (2015-2020)
Table 43. Europe Decoagulant Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Decoagulant Revenue Market Share by Country (2015-2020)
Table 45. Europe Decoagulant Sales by Type (2015-2020) (K Doses)
Table 46. Europe Decoagulant Sales Market Share by Type (2015-2020)
Table 47. Europe Decoagulant Sales by Application (2015-2020) (K Doses)
Table 48. Europe Decoagulant Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Decoagulant Sales by Region (2015-2020) (K Doses)
Table 50. Asia Pacific Decoagulant Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Decoagulant Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Decoagulant Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Decoagulant Sales by Type (2015-2020) (K Doses)
Table 54. Asia Pacific Decoagulant Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Decoagulant Sales by Application (2015-2020) (K Doses)
Table 56. Asia Pacific Decoagulant Sales Market Share by Application (2015-2020)
Table 57. Latin America Decoagulant Sales by Country (2015-2020) (K Doses)
Table 58. Latin America Decoagulant Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Decoagulant Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Decoagulant Revenue Market Share by Country (2015-2020)
Table 61. Latin America Decoagulant Sales by Type (2015-2020) (K Doses)
Table 62. Latin America Decoagulant Sales Market Share by Type (2015-2020)
Table 63. Latin America Decoagulant Sales by Application (2015-2020) (K Doses)
Table 64. Latin America Decoagulant Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Decoagulant Sales by Country (2015-2020) (K Doses)
Table 66. Middle East and Africa Decoagulant Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Decoagulant Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Decoagulant Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Decoagulant Sales by Type (2015-2020) (K Doses)
Table 70. Middle East and Africa Decoagulant Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Decoagulant Sales by Application (2015-2020) (K Doses)
Table 72. Middle East and Africa Decoagulant Sales Market Share by Application (2015-2020)
Table 73. Sanofi Corporation Information
Table 74. Sanofi Description and Major Businesses
Table 75. Sanofi Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Sanofi Product
Table 77. Sanofi Recent Development
Table 78. Bayer Corporation Information
Table 79. Bayer Description and Major Businesses
Table 80. Bayer Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. Bayer Product
Table 82. Bayer Recent Development
Table 83. Boehringer Ingelheim Corporation Information
Table 84. Boehringer Ingelheim Description and Major Businesses
Table 85. Boehringer Ingelheim Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. Boehringer Ingelheim Product
Table 87. Boehringer Ingelheim Recent Development
Table 88. Johnson & Johnson Corporation Information
Table 89. Johnson & Johnson Description and Major Businesses
Table 90. Johnson & Johnson Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Recent Development
Table 93. Genentech (Roche) Corporation Information
Table 94. Genentech (Roche) Description and Major Businesses
Table 95. Genentech (Roche) Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Genentech (Roche) Product
Table 97. Genentech (Roche) Recent Development
Table 98. AstraZeneca Corporation Information
Table 99. AstraZeneca Description and Major Businesses
Table 100. AstraZeneca Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. AstraZeneca Product
Table 102. AstraZeneca Recent Development
Table 103. Bristol-Myers Squibb Corporation Information
Table 104. Bristol-Myers Squibb Description and Major Businesses
Table 105. Bristol-Myers Squibb Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Recent Development
Table 108. Aspen Corporation Information
Table 109. Aspen Description and Major Businesses
Table 110. Aspen Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. Aspen Product
Table 112. Aspen Recent Development
Table 113. Lilly Corporation Information
Table 114. Lilly Description and Major Businesses
Table 115. Lilly Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Lilly Product
Table 117. Lilly Recent Development
Table 118. Otsuka Corporation Information
Table 119. Otsuka Description and Major Businesses
Table 120. Otsuka Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Otsuka Product
Table 122. Otsuka Recent Development
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Major Businesses
Table 125. Pfizer Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 126. Pfizer Product
Table 127. Pfizer Recent Development
Table 128. Daiichi Sankyo Corporation Information
Table 129. Daiichi Sankyo Description and Major Businesses
Table 130. Daiichi Sankyo Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 131. Daiichi Sankyo Product
Table 132. Daiichi Sankyo Recent Development
Table 133. The Medicines Company Corporation Information
Table 134. The Medicines Company Description and Major Businesses
Table 135. The Medicines Company Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 136. The Medicines Company Product
Table 137. The Medicines Company Recent Development
Table 138. Global Decoagulant Sales Forecast by Regions (2021-2026) (K Doses)
Table 139. Global Decoagulant Sales Market Share Forecast by Regions (2021-2026)
Table 140. Global Decoagulant Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 141. Global Decoagulant Revenue Market Share Forecast by Regions (2021-2026)
Table 142. North America: Decoagulant Sales Forecast by Country (2021-2026) (K Doses)
Table 143. North America: Decoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Europe: Decoagulant Sales Forecast by Country (2021-2026) (K Doses)
Table 145. Europe: Decoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Asia Pacific: Decoagulant Sales Forecast by Region (2021-2026) (K Doses)
Table 147. Asia Pacific: Decoagulant Revenue Forecast by Region (2021-2026) (US$ Million)
Table 148. Latin America: Decoagulant Sales Forecast by Country (2021-2026) (K Doses)
Table 149. Latin America: Decoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Middle East and Africa: Decoagulant Sales Forecast by Country (2021-2026) (K Doses)
Table 151. Middle East and Africa: Decoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 153. Key Challenges
Table 154. Market Risks
Table 155. Main Points Interviewed from Key Decoagulant Players
Table 156. Decoagulant Customers List
Table 157. Decoagulant Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Decoagulant Product Picture
Figure 2. Global Decoagulant Sales Market Share by Type in 2020 & 2026
Figure 3. Platelet aggregation inhibitors (PAI) Product Picture
Figure 4. Low-molecular-weight Heparin (LMWH) Product Picture
Figure 5. Direct thrombin inhibitor (DTI) Product Picture
Figure 6. Direct factor Xa inhibitors (DFXa) Product Picture
Figure 7. Vitamin K antagonists (VKA) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Decoagulant Sales Market Share by Application in 2020 & 2026
Figure 10. VTE
Figure 11. ACS/MI
Figure 12. AF
Figure 13. Others
Figure 14. Decoagulant Report Years Considered
Figure 15. Global Decoagulant Market Size 2015-2026 (US$ Million)
Figure 16. Global Decoagulant Sales 2015-2026 (K Doses)
Figure 17. Global Decoagulant Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Decoagulant Sales Market Share by Region (2015-2020)
Figure 19. Global Decoagulant Sales Market Share by Region in 2019
Figure 20. Global Decoagulant Revenue Market Share by Region (2015-2020)
Figure 21. Global Decoagulant Revenue Market Share by Region in 2019
Figure 22. Global Decoagulant Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Decoagulant Revenue in 2019
Figure 24. Decoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Decoagulant Sales Market Share by Type (2015-2020)
Figure 26. Global Decoagulant Sales Market Share by Type in 2019
Figure 27. Global Decoagulant Revenue Market Share by Type (2015-2020)
Figure 28. Global Decoagulant Revenue Market Share by Type in 2019
Figure 29. Global Decoagulant Market Share by Price Range (2015-2020)
Figure 30. Global Decoagulant Sales Market Share by Application (2015-2020)
Figure 31. Global Decoagulant Sales Market Share by Application in 2019
Figure 32. Global Decoagulant Revenue Market Share by Application (2015-2020)
Figure 33. Global Decoagulant Revenue Market Share by Application in 2019
Figure 34. North America Decoagulant Sales Growth Rate 2015-2020 (K Doses)
Figure 35. North America Decoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Decoagulant Sales Market Share by Country in 2019
Figure 37. North America Decoagulant Revenue Market Share by Country in 2019
Figure 38. U.S. Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 39. U.S. Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 41. Canada Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Decoagulant Market Share by Type in 2019
Figure 43. North America Decoagulant Market Share by Application in 2019
Figure 44. Europe Decoagulant Sales Growth Rate 2015-2020 (K Doses)
Figure 45. Europe Decoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Decoagulant Sales Market Share by Country in 2019
Figure 47. Europe Decoagulant Revenue Market Share by Country in 2019
Figure 48. Germany Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Germany Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 51. France Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 53. U.K. Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Italy Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Decoagulant Market Share by Type in 2019
Figure 59. Europe Decoagulant Market Share by Application in 2019
Figure 60. Asia Pacific Decoagulant Sales Growth Rate 2015-2020 (K Doses)
Figure 61. Asia Pacific Decoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Decoagulant Sales Market Share by Region in 2019
Figure 63. Asia Pacific Decoagulant Revenue Market Share by Region in 2019
Figure 64. China Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 65. China Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Japan Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 69. South Korea Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 71. India Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Australia Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Taiwan Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Indonesia Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Thailand Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Malaysia Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Philippines Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Vietnam Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Decoagulant Market Share by Type in 2019
Figure 87. Asia Pacific Decoagulant Market Share by Application in 2019
Figure 88. Latin America Decoagulant Sales Growth Rate 2015-2020 (K Doses)
Figure 89. Latin America Decoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Decoagulant Sales Market Share by Country in 2019
Figure 91. Latin America Decoagulant Revenue Market Share by Country in 2019
Figure 92. Mexico Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Mexico Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Brazil Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 97. Argentina Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Decoagulant Market Share by Type in 2019
Figure 99. Latin America Decoagulant Market Share by Application in 2019
Figure 100. Middle East and Africa Decoagulant Sales Growth Rate 2015-2020 (K Doses)
Figure 101. Middle East and Africa Decoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Decoagulant Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Decoagulant Revenue Market Share by Country in 2019
Figure 104. Turkey Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 105. Turkey Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 107. Saudi Arabia Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Decoagulant Sales Growth Rate (2015-2020) (K Doses)
Figure 109. U.A.E Decoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Decoagulant Market Share by Type in 2019
Figure 111. Middle East and Africa Decoagulant Market Share by Application in 2019
Figure 112. North America Decoagulant Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. North America Decoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Decoagulant Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Europe Decoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Decoagulant Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Asia Pacific Decoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Decoagulant Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 119. Latin America Decoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Decoagulant Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 121. Middle East and Africa Decoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
超低分子量ヘパリン（ULMWH）の世界市場（～2026年） Market Analysis and Insights: Global Ultra-low Molecular Weight Heparin (ULMWH) Market The global Ultra-low Molecular Weight Heparin (ULMWH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ultra-low Molecular Weight He…- 腫瘍壊死因子α阻害剤の世界市場（～2026年） The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…
- 腫瘍壊死因子阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Market The global Tumor Necrosis Factor Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Scope and Market…
- 分子量マーカーの世界市場（～2026年） Molecular weight markers are used to calculate sample molecular weights in the medical research arena. In addition, these markers play a vital role in the monitoring of the progress of an electrophoretic run in separation and analysis of macromolecules. Molecular weight markers include RNA, DNA, and…
- 核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…